BCL2 and lung carcinoma: In the present study, we observed induction of apoptosis in honokiol-treated KRAS mutant lung cancer cells, which was supported by an increased amount of cleaved PARP and pro-apoptotic proteins Bax, with a reduction of anti-apoptotic Bcl-2 protein.